Champions Oncology, Inc. (CSBR)
NASDAQ: CSBR · Real-Time Price · USD
4.790
+0.030 (0.63%)
At close: Nov 6, 2026, 4:00 PM EST
4.830
+0.040 (0.84%)
After-hours: Nov 6, 2026, 7:30 PM EST
Champions Oncology Market Cap
Champions Oncology has a market cap or net worth of $66.67 million as of November 6, 2026. It is the 27,751st most valuable company in the world and the 4,381st biggest in the United States. Its market cap has decreased by 28.92% in one year.
Market Cap
66.67M
Enterprise Value
73.28M
1-Year Change
-28.92%
Global Rank
Country Rank
#4,381 United States
Category
ChartMarket Cap Chart
Since August 21, 2015, Champions Oncology's market cap has increased from $45.90M to $66.67M, an increase of 45.25%. That is a compound annual growth rate of 3.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 66.70M | -30.52% |
| Dec 31, 2025 | 96.00M | -18.92% |
| Dec 31, 2024 | 118.40M | 54.97% |
| Dec 29, 2023 | 76.40M | 25.04% |
| Dec 30, 2022 | 61.10M | -45.93% |
| Dec 31, 2021 | 113.00M | -21.69% |
| Dec 31, 2020 | 144.30M | 49.07% |
| Dec 31, 2019 | 96.80M | 8.04% |
| Dec 31, 2018 | 89.60M | 110.33% |
| Dec 29, 2017 | 42.60M | 53.79% |
| Dec 30, 2016 | 27.70M | -10.93% |
| Dec 31, 2015 | 31.10M | -32.24% |
| Aug 21, 2015 | 45.90M | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MediciNova | 71.86M |
| Coya Therapeutics | 70.14M |
| Conexeu Sciences | 69.68M |
| Acrivon Therapeutics | 68.99M |
| Nutriband | 67.46M |
| Cognition Therapeutics | 65.33M |
| MAIA Biotechnology | 64.48M |
| Nordicus Partners | 62.70M |